Bristol Myers backs a European VC's record-setting biotech venture fund, which tops out at $600M
A European biotech venture group with a yen for transatlantic deals will face whatever is coming on the investment side of the business with a new fund that claims boasting rights as the largest life sciences fund ever raised on the continent.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
